A LinkedIn post from Segmed highlights an upcoming “Bytes of Innovation” session focused on building and operationalizing an in-house clinical AI program in radiology. The event on March 10 will feature Martina Aineseder, M.D., who is described as Head Radiologist of the AI in Health Program at Hospital Italiano de Buenos Aires and a clinical consultant to Segmed.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
According to the post, the session will address why some healthcare institutions opt for internally developed AI tools over commercial offerings, as well as approaches to evaluation, validation, and deployment. It also references head-to-head benchmarking of proprietary versus commercial models and emphasizes the role of multidisciplinary collaboration in clinical AI initiatives.
The content suggests Segmed is positioning itself as a thought partner in clinical AI and medical imaging workflow integration rather than solely as a technology vendor. By centering on issues like workflow integration and clinician adoption, the post points to Segmed’s focus on practical implementation challenges that are critical for hospital purchasing decisions and long-term AI utilization.
For investors, this emphasis on education and frameworks for the “buy vs. build” decision in AI may signal a strategy aimed at deeper engagement with radiologists, healthcare leaders, and data scientists in key markets such as Latin America. If these initiatives help Segmed influence standards for clinical AI evaluation and deployment, the company could strengthen its competitive position and potentially expand its addressable customer base in the medical imaging and healthtech sectors.